6RASMUSEN M, KARYPIS G. gCLUTO: An interactive clustering, visualization, and analysis system [ R ]. UMN - CS TR -04 -021, 2004.
7OLANOW C W, LEES A, OBESO J. Levodopa therapy for Parkinson' s disease: challenges and future prospects [J]. Mov Disord, 2008, 23 ($3): $495-$496.
8FUJINO J, TANAKA H, TANIGUCHI N, et al. Effec-tiveness of aripiprazole in a patient with presumed idio- pathic Parkinson' s disease and chronic paranoid schizo- phrenia [ J ]. Psychiatry Clin Neurosci, 2010 , 64 (1): 105-109.
9YU L, HU F, ZOU X, et al. LRRK2 R1628P contrib- utes to Parkinson' s disease susceptibility in Chinese Han populations from China's Mainland [ J ]. Brain Res, 2009 (1296) : 113 -116.
10LOHMANN E, LECLERE L, DE ANNA F, et al. A clinical, neuropsychological and olfactory evaluation of a large family with LRRK2 mutations [ J ]. Parkinsonism Relat Disord, 2009, 15 (4): 273-276.
